Adamis Pharmaceuticals reported $-8175910 in EBIT for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Brainstorm Cell Therapeutics BCLI:US USD -6841000 750K
Cara Therapeutics CARA:US USD -23845000 19.37M
GlaxoSmithKline GSK:LN GBP 2.41B 591M
Glaxosmithkline GSK:US GBP 2.41B 591M
Merk MRK:US USD 5.56B 156M
Pfizer PFE:US USD 9.7B 2.43B